Clinical Research Directory
Browse clinical research sites, groups, and studies.
Acetazolamide Add-On Therapy to OSA Surgery
Sponsor: University Hospital, Antwerp
Summary
Surgical procedures are routinely performed as an alternative to continuous positive airway pressure treatment in patients with obstructive sleep apnea (OSA). However, the response to surgery is often variable. Instability of the respiratory control during sleep (or high loop gain) has been associated with poor surgical results in previous research. Acetazolamide (AZM), a carbonic anhydrase inhibitor, has shown potential in reducing loop gain without affecting other physiological OSA traits. In this protocol the investigators will evaluate the clinical efficacy of AZM add-on therapy to surgical procedures in patients with OSA.
Official title: Acetazolamide as add-on Therapy to Obstructive Sleep Apnea Surgery (ACTOS): a Parallel-group, Double-blind, Placebo-controlled, Randomized Trial
Key Details
Gender
All
Age Range
18 Years - 75 Years
Study Type
INTERVENTIONAL
Enrollment
26
Start Date
2020-01-22
Completion Date
2024-08
Last Updated
2024-06-18
Healthy Volunteers
No
Conditions
Interventions
Acetazolamide
Oral acetazolamide tablets of 250 mg taken twice daily.
Placebo
Matching placebo tablets taken twice daily.
Locations (1)
Antwerp University Hospital
Edegem, Antwerp, Belgium